Carlyle Group divests 4.3% stake in Indegene for Rs 636 crore
New Delhi: Carlyle Group, a global investment firm, through its arm divested a 4.3 percent stake in Indegene, a healthcare tech firm, for Rs 636 crore. Divestment was carried out through an open market transaction.
CA Dawn Investments, an affiliate of US-based Carlyle, sold 1,02,63,785 shares amounting to a 4.3% stake in Indegene, as per the bulk deal data available on the National Stock Exchange (NSE).
The shares were offloaded at an average price of ₹619.82 apiece, bringing the value of transaction to Rs 636.17 crore, according to PTI.
Following this sale, Carlyle's holding in Indegene has reduced to 10.22% from 14.52%.
Details of the buyers of Indegene's shares could not be ascertained on the NSE.
In two separate deals on the NSE and BSE, financial services company Capital Group on Tuesday trimmed its holding by selling a 2.24% stake in Medi Assist Healthcare Services for nearly ₹93 crore through open market transactions.
Capital through its arm SmallCap World Fund Inc sold a total of 15.75 lakh shares, or 2.24% stake in Medi Assist Healthcare Services on the NSE and BSE, as per the data.
The shares were disposed of at an average price of ₹588 apiece on both exchanges, taking the combined deal value to ₹92.65 crore.
After the stake sale, Capital Group through its arm SmallCap World Fund Inc's shareholding in Medi Assist Healthcare Services has declined to 0.7% from 2.93%. Details of the buyers of Medi Assist Healthcare Services could not be identified on the exchanges.
On Tuesday, shares of Medi Assist Healthcare Services rose 0.18% to close at ₹588.20 apiece on the BSE, while it settled 0.06% lower at ₹586.20 per piece on the NSE
Read also: Shares of Indegene listed with nearly 46 percent premium
Next Story